Intrexon and Merck Serono announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies Read the full story

Illumina has formed a collaboration with Merck Serono to develop a universal next-generation sequencing (NGS)-based oncology diagnostic Read the full story

Merck KGaA is conducting an ongoing assessment of its pipeline assets and has decided to return the rights of Sym004 to Symphogen for further development Read the full story

Merck KGaA has entered into a global agreement with Pfizer to co-develop and co-commercialize MSB0010718C Read the full story

Ventana Medical Systems has entered into an agreement with, big pharma, Merck KGaA to collaborate on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. Read the full story

Dako announced a pharma deal with Merck & Co to develop a companion diagnostic test for the analysis of the potential tumor biomarker PD-L1 to aid in the treatment of cancer. Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Merck KGaA is a top pharmaceutical company based in Darmstadt, Germany Read the full story

Life Technologies announces pharma partnering with Merck Serono on current and future companion diagnostics projects Read the full story

Merck KgaA / Merck Serono is a top pharma company active in partnering, licensing and M&A in biopharmaceuticals, consumer healthcare and research equipment Read the full story